Clinical trials
Withdrawn Phase 4 Breast Neoplasms trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
10 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2010 | 2 |
| 2014 | 2 |
| 2016 | 1 |
| 2018 | 2 |
| 2019 | 1 |
| 2020 | 1 |
| 2022 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Withdrawn | 10 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Hoffmann-La Roche | 2 |
| Dartmouth-Hitchcock Medical Center | 1 |
| Eli Lilly and Company | 1 |
| Fred Hutchinson Cancer Center | 1 |
| The University of Texas Health Science Center, Houston | 1 |
| Timothy R Petersen | 1 |
| University Hospital, Ghent | 1 |
| University of Arkansas | 1 |
| Woman's | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Breast Neoplasms | 10 |
| Postoperative Pain | 2 |
| Brain Neoplasms | 1 |
| Breast Carcinoma In Situ | 1 |
| Gastrointestinal Neoplasms | 1 |
| Head and Neck Neoplasms | 1 |
| Insulin Resistance | 1 |
| Lung Neoplasms | 1 |
| Melanoma | 1 |
| Neoplasm Metastasis | 1 |
Trials
Showing 1 to 10 of 10. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.